adapalene has been researched along with Innate Inflammatory Response in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Ahrens, NS; Kamali, SA; Mastbergen, SC; Meij, BP; Narcisi, R; Sivasubramaniyan, K; Snel, L; Teunissen, M; Tryfonidou, MA; van Osch, GJVM | 1 |
| Baalbaki, N; Colon, G; Draelos, ZD; Dreno, B | 1 |
| Draelos, Z; Eichenfield, LF; Hebert, AA; Liu, H; Lucky, AW; Manna, V; Rudisill, D; Stein Gold, L; Sugarman, J | 1 |
| Babaeinejad, SH; Fouladi, RF | 1 |
| Leoni, M; Liu, H; Rueda, MJ; Stein Gold, L; Tanghetti, E; Weiss, J | 1 |
| Horan, G; Kosek, J; Lotti, R; Marconi, A; Parton, A; Pincelli, C; Quadri, M; Saltari, A; Schafer, PH; Truzzi, F; Wu, L; Zhang, LH | 1 |
| Leyden, J | 2 |
| Furue, M; Hachisuka, J; Moroi, Y; Shidahara, S; Yunotani, S | 1 |
| Gold, MH; Graeber, M; Liu, Y; Morris, A; Pariser, DM; Westmoreland, P | 1 |
| Algate, D; Bouclier, M; Cavey, D; Chatelus, A; Eustache, J; Hensby, C; Shroot, B | 1 |
2 review(s) available for adapalene and Innate Inflammatory Response
| Article | Year |
|---|---|
How does our increased understanding of the role of inflammation and innate immunity in acne impact treatment approaches?
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Drug Combinations; Humans; Immunity, Innate; Inflammation | 2016 |
Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acne.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Doxycycline; Drug Combinations; Gels; Humans; Inflammation; Isotretinoin | 2016 |
5 trial(s) available for adapalene and Innate Inflammatory Response
| Article | Year |
|---|---|
Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Double-Blind Method; Drug Combinations; Erythema; Gels; Humans; Inflammation; Skin Care; Treatment Outcome | 2023 |
Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Child; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Inflammation; Male; Naphthalenes; Quality of Life; Severity of Illness Index; Treatment Outcome | 2013 |
The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Double-Blind Method; Female; Follow-Up Studies; Gels; Humans; In Vitro Techniques; Inflammation; Male; Naphthalenes; Patient Satisfaction; Treatment Outcome; Young Adult | 2013 |
Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
Topics: Acne Vulgaris; Adapalene; Adult; Benzoyl Peroxide; Chemistry, Pharmaceutical; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Inflammation; Keratolytic Agents; Male; Treatment Outcome; Young Adult | 2015 |
Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Inflammation; Male; Naphthalenes; Retinoids; Skin; Time Factors; Treatment Outcome | 2007 |
4 other study(ies) available for adapalene and Innate Inflammatory Response
| Article | Year |
|---|---|
Synovial membrane-derived mesenchymal progenitor cells from osteoarthritic joints in dogs possess lower chondrogenic-, and higher osteogenic capacity compared to normal joints.
Topics: Adapalene; Animals; Cell Adhesion Molecules; Cell Differentiation; Cells, Cultured; Dogs; Inflammation; Mesenchymal Stem Cells; Osteoarthritis; Synovial Membrane; Synovitis; Thy-1 Antigens | 2022 |
Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex.
Topics: Adapalene; Adult; Cell Differentiation; Cell Movement; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Dermis; Female; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Immunoprecipitation; Inflammation; Inflammation Mediators; Isoenzymes; Leukocytes, Mononuclear; Male; Myofibroblasts; Psoriasis; Thalidomide | 2016 |
Effect of adapalene on cetuximab-induced painful periungual inflammation.
Topics: Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cetuximab; Humans; Inflammation; Male; Middle Aged; Nail Diseases; Naphthalenes | 2011 |
The in vivo and in vitro anti-inflammatory activity of CD271: a new retinoid-like modulator of cell differentiation.
Topics: Adapalene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Carrageenan; Cell Differentiation; Chemotaxis, Leukocyte; Croton Oil; Erythema; Guinea Pigs; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Inflammation; Lipoxygenase; Luminescent Measurements; Mice; Naphthalenes; Neutrophils; Passive Cutaneous Anaphylaxis; Rabbits; Rats; Ultraviolet Rays | 1990 |